What are the recommended starting and maximum oral doses for commonly used β‑blockers?

Beta-Blocker Starting and Maximum Doses

For heart failure with reduced ejection fraction (HFrEF), initiate bisoprolol at 1.25 mg once daily and titrate to a target of 10 mg once daily; carvedilol at 3.125 mg twice daily titrated to 25–50 mg twice daily; or metoprolol succinate at 12.5–25 mg once daily titrated to 200 mg once daily. 1, 2

Evidence-Based Beta-Blockers for Heart Failure

The three beta-blockers with proven mortality reduction in HFrEF have specific dosing protocols derived from landmark clinical trials:

Bisoprolol

• Starting dose: 1.25 mg once daily 2
• Target dose: 10 mg once daily 1, 2
• Titration: Initiate at very low doses with gradual incremental increases every 2 weeks if lower doses are well tolerated 1

Carvedilol (Immediate Release)

• Starting dose: 3.125 mg twice daily 3, 2
• Target dose: 25 mg twice daily (standard); 50 mg twice daily for patients >85 kg 3, 1, 2
• Maximum dose: 50 mg total daily (25 mg twice daily for most patients) 1
• Titration: Double the dose every 1–2 weeks as tolerated 4

Carvedilol Extended Release

• Starting dose: Not specified for initial therapy 1
• Target dose: 80 mg once daily 1
• Maximum dose: 80 mg once daily 1

Metoprolol Succinate (Sustained Release)

• Starting dose: 12.5–25 mg once daily 2
• Target dose: 200 mg once daily 1, 2
• Maximum dose: 200 mg once daily 1

Beta-Blockers for Angina and Coronary Disease

For patients with unstable angina/NSTEMI or chronic stable angina, different beta-blockers are used with distinct dosing:

Metoprolol Tartrate

• Starting dose: 50 mg twice daily 3
• Target dose: 50–200 mg twice daily 3
• For acute MI (IV to oral transition): 5 mg IV increments over 1–2 minutes, repeated every 5 minutes for total of 15 mg, then 25–50 mg orally every 6 hours for 48 hours, followed by maintenance up to 100 mg twice daily 3

Atenolol

• Starting dose: 50 mg once daily 3
• Target dose: 50–200 mg once daily 3

Propranolol (Immediate Release)

• Starting dose: 20 mg twice daily 3
• Target dose: 20–80 mg twice daily 3

Propranolol (Long-Acting)

• Starting dose: 80 mg once daily 5
• Target dose: 80–160 mg once daily 5

Nadolol

• Starting dose: 40 mg once daily 3
• Target dose: 40–80 mg once daily 3

Labetalol (combined alpha/beta blocker)

• Starting dose: 200 mg twice daily 3
• Target dose: 200–600 mg twice daily 3

Beta-Blockers for Hypertension

For hypertension management, cardioselective agents are preferred:

Bisoprolol

• Starting dose: 2.5 mg once daily 5
• Target dose: 2.5–10 mg once daily 5

Metoprolol Tartrate

• Starting dose: 100 mg twice daily 5
• Target dose: 100–200 mg twice daily 5

Metoprolol Succinate

• Starting dose: 50 mg once daily 5
• Target dose: 50–200 mg once daily 5

Atenolol

• Starting dose: 25 mg twice daily 5
• Target dose: 25–100 mg twice daily 5

Nebivolol (vasodilatory properties)

• Starting dose: 5 mg once daily 5
• Target dose: 5–40 mg once daily 5
• Heart failure starting dose: 1.25 mg once daily titrated to 10 mg once daily 2

Carvedilol (for hypertension without HF)

• Starting dose: 6.25 mg twice daily 5
• Target dose: 12.5–25 mg twice daily 5
• Maximum dose: 25 mg twice daily (total 50 mg/day) 4

Critical Titration Principles

Dose escalation should occur no more frequently than every 2 weeks to achieve target doses or maximally tolerated doses. 1

• Monitor heart rate: Hold escalation if resting heart rate <50–60 bpm with symptoms 3, 6
• Monitor blood pressure: Assess for orthostatic hypotension 1 hour after each dose 4
• Assess fluid status: Check for weight gain >2 kg, peripheral edema, or signs of congestion 4
• Evaluate symptoms: Watch for worsening dyspnea, fatigue, or reduced exercise tolerance 4

Key Clinical Pitfalls

Never attempt dose-equivalency calculations between different beta-blockers; always start with the guideline-recommended low dose for the specific agent. 4

• Avoid early IV beta-blockers in hemodynamically unstable patients, those with heart failure signs, hypotension, or high risk of cardiogenic shock 3
• Do not use cardioselective beta-blockers as first-line for hypertension unless the patient has ischemic heart disease or heart failure 5
• Avoid abrupt discontinuation of any beta-blocker, particularly in patients with coronary disease, as this may precipitate acute coronary syndrome 5
• Use extreme caution with non-cardioselective agents (propranolol, nadolol) in patients with reactive airway disease; cardioselective agents (bisoprolol, metoprolol) are preferred but still require careful monitoring 7
• Do not overlap two beta-blockers when switching agents; discontinue the first before initiating the second 4

Special Populations

For patients with hypertrophic cardiomyopathy and symptoms, titrate beta-blockers to achieve a resting heart rate <60–65 bpm, up to generally accepted maximum doses. 6

In acute stroke with severe hypertension (systolic >220 or diastolic 121–140 mm Hg), labetalol 10–20 mg IV over 1–2 minutes may be repeated every 10 minutes to a maximum of 300 mg. 8

For hypertensive emergencies, esmolol provides ultra-short-acting beta-blockade with a loading dose of 500–1000 mcg/kg/min over 1 minute, followed by 50 mcg/kg/min infusion, titrated up to 200 mcg/kg/min maximum. 9